Table 1.
Baseline characteristics of all enrolled patients (n = 74)
| Characteristic | Usual care (N=25) |
Loose control (N=25) |
Tight control (N=24) |
|---|---|---|---|
| Median age, years (IQR) | 66 (53–73) | 71 (62–80) | 68 (58–74) |
| Men, N (%) | 15 (60%) | 13 (52%) | 13 (54%) |
| Median NIHSS (IQR) | 8 (4–16) | 8 (5–16) | 8 (6–10) |
| Diabetes mellitus*, N (%) | 19 (76%) | 13 (52%) | 12 (50%) |
| Treatment with IV rt-PA, N (%) | 10 (40%) | 7 (28%) | 9 (38%) |
| Lacunar stroke subtype N (%) | 3 (12%) | 9 (36%) | 7 (29%) |
| Median blood glucose, mg/dL (IQR) | 143 (133–185) | 168 (133–221) | 167 (142–229) |
| African American N (%) | 7 (28%) | 10 (40%) | 7 (29%) |
| Median hours to randomization (IQR) | 10.4 (6.4–16.8) | 10.6 (7.0–15.2) | 12.3 (7.1–15.2) |
NIHSS – NIH Stroke Scale; IQR – interquartile range,
*
Diabetes mellitus defined as known history of diabetes prior to enrollment in trial